Reardon Andrew
CLO & Secretary
CIK: 1950232
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 100 | $197.70 | $19,769.54 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 100 | $199.00 | $19,900.50 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 207 | $199.96 | $41,390.89 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 93 | $200.62 | $18,657.89 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 300 | $201.70 | $60,510.00 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 200 | $204.17 | $40,834.00 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 460 | $205.18 | $94,381.88 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 340 | $206.37 | $70,164.78 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 612 | $207.01 | $126,689.45 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 1,446 | $208.12 | $300,939.06 | View Details Filing |
| Mar 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | S | 1,142 | $208.87 | $238,532.28 | View Details Filing |